Ranolazine Patent Expiration
Ranolazine was first introduced by Menarini International Operations Luxembourg Sa
Ranolazine Patents
Given below is the list of patents protecting Ranolazine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Aspruzyo Sprinkle | US10898444 | Extended release multiparticulates of ranolazine | Jan 24, 2038 | Spil |
| Aspruzyo Sprinkle | US11510878 | Extended release multiparticulates of ranolazine | Jan 24, 2038 | Spil |
| Aspruzyo Sprinkle | US12161761 | Extended release multiparticulates of ranolazine | Jan 24, 2038 | Spil |
| Ranexa | US6303607 | Method for administering a sustained release ranolanolazine formulation |
May 27, 2019
(Expired) | Menarini Intl |
| Ranexa | US6369062 | Sustained release ranolazine formulations |
May 27, 2019
(Expired) | Menarini Intl |
| Ranexa | US6479496 | Methods for treating angina with ranolazine |
May 27, 2019
(Expired) | Menarini Intl |
| Ranexa | US6503911 | Sustained release ranolazine formulations |
May 27, 2019
(Expired) | Menarini Intl |
| Ranexa | US6525057 | Sustained release ranolazine formulations |
May 27, 2019
(Expired) | Menarini Intl |
| Ranexa | US6562826 | Sustained release ranolazine formulations |
May 27, 2019
(Expired) | Menarini Intl |
| Ranexa | US6617328 | Sustained release ranolazine formulations |
May 27, 2019
(Expired) | Menarini Intl |
| Ranexa | US6620814 | Sustained release ranolazine formulations |
May 27, 2019
(Expired) | Menarini Intl |
| Ranexa | US6852724 | Sustained release ranolazine formulations |
May 27, 2019
(Expired) | Menarini Intl |
| Ranexa | US6864258 | Sustained release ranolazine formulations |
May 27, 2019
(Expired) | Menarini Intl |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Ranolazine's patents.
Latest Legal Activities on Ranolazine's Patents
Given below is the list recent legal activities going on the following patents of Ranolazine.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| File Marked Found | 20 Dec, 2016 | US6620814(Litigated) |
| File Marked Found | 15 Dec, 2016 | US6525057(Litigated) |
| File Marked Found | 12 Dec, 2016 | US6525057(Litigated) |
| Post Issue Communication - Certificate of Correction | 11 Aug, 2015 | US6562826(Litigated) |
| Case Docketed to Examiner in GAU Critical | 05 Aug, 2015 | US6562826(Litigated) |
| Post Issue Communication - Certificate of Correction | 19 Mar, 2015 | US6620814(Litigated) |
| Post Issue Communication - Certificate of Correction | 21 Jan, 2015 | US6852724(Litigated) |
| Correspondence Address Change Critical | 01 Mar, 2012 | US6525057(Litigated) |
| Correspondence Address Change Critical | 01 Mar, 2012 | US6562826(Litigated) |
| Correspondence Address Change Critical | 01 Mar, 2012 | US6503911(Litigated) |
Ranolazine's Family Patents
Explore Our Curated Drug Screens
Ranolazine Generic API Manufacturers
Several generic applications have been filed for Ranolazine. The first generic version for Ranolazine was by Chartwell Rx Sciences Llc and was approved on Jul 29, 2013. And the latest generic version is by Jubilant Generics Ltd and was approved on Apr 15, 2025.
Given below is the list of companies who have filed for Ranolazine generic, along with the locations of their manufacturing plants worldwide.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1GM | tablet, extended release | Discontinued | ORAL | N/A | May 18, 2021 |
| 500MG | tablet, extended release | Discontinued | ORAL | N/A | May 18, 2021 |
2. ACTAVIS ELIZABETH
Actavis Elizabeth Llc has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet, extended release | Prescription | ORAL | AB | May 28, 2019 |
| 1GM | tablet, extended release | Prescription | ORAL | AB | May 28, 2019 |
Manufacturing Plant Locations New
Actavis Elizabeth's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Elizabeth as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
3. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet, extended release | Prescription | ORAL | AB | May 28, 2019 |
| 1GM | tablet, extended release | Prescription | ORAL | AB | May 28, 2019 |
Manufacturing Plant Locations New
Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
4. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet, extended release | Prescription | ORAL | AB | Nov 30, 2020 |
| 1GM | tablet, extended release | Prescription | ORAL | AB | Nov 30, 2020 |
5. AMNEAL
Amneal Pharmaceuticals Llc has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1GM | tablet, extended release | Discontinued | ORAL | N/A | Mar 11, 2021 |
| 500MG | tablet, extended release | Discontinued | ORAL | N/A | Mar 11, 2021 |
Manufacturing Plant Locations New
Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
6. ANI PHARMS
Ani Pharmaceuticals Inc has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Ani Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1GM | tablet, extended release | Discontinued | ORAL | N/A | Oct 29, 2019 |
| 500MG | tablet, extended release | Discontinued | ORAL | N/A | Oct 29, 2019 |
7. ARTHUR GRP
Arthur Group Llc has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Arthur Grp.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet, extended release | Prescription | ORAL | AB | Mar 23, 2020 |
| 1GM | tablet, extended release | Prescription | ORAL | AB | Mar 23, 2020 |
8. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet, extended release | Prescription | ORAL | AB | Dec 23, 2022 |
| 1GM | tablet, extended release | Prescription | ORAL | AB | Dec 23, 2022 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
| United States |
| |||||||||
9. CADILA
Cadila Healthcare Ltd has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Cadila.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet, extended release | Prescription | ORAL | AB | Aug 19, 2019 |
| 1GM
(reference standard) | tablet, extended release | Prescription | ORAL | AB | Aug 19, 2019 |
Manufacturing Plant Locations New
Cadila's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Cadila as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| India |
| |||||
10. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet, extended release | Prescription | ORAL | AB | Jul 29, 2013 |
| 1GM | tablet, extended release | Prescription | ORAL | AB | Jul 29, 2013 |
11. CIPLA
Cipla Ltd has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet, extended release | Discontinued | ORAL | N/A | May 28, 2019 |
| 1GM | tablet, extended release | Discontinued | ORAL | N/A | May 28, 2019 |
Manufacturing Plant Locations New
Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
12. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1GM | tablet, extended release | Prescription | ORAL | AB | Jul 5, 2019 |
| 500MG | tablet, extended release | Prescription | ORAL | AB | Jul 5, 2019 |
13. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1GM | tablet, extended release | Prescription | ORAL | AB | May 5, 2022 |
| 500MG | tablet, extended release | Prescription | ORAL | AB | May 5, 2022 |
14. I3 PHARMS
I3 Pharmaceuticals Llc has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by I3 Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet, extended release | Prescription | ORAL | AB | Apr 27, 2022 |
| 1GM | tablet, extended release | Prescription | ORAL | AB | Apr 27, 2022 |
15. JUBILANT GENERICS
Jubilant Generics Ltd has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Jubilant Generics.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1GM | tablet, extended release | Prescription | ORAL | AB | Apr 15, 2025 |
| 500MG | tablet, extended release | Prescription | ORAL | AB | Apr 15, 2025 |
Manufacturing Plant Locations New
Jubilant Generics's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Jubilant Generics as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
16. MANKIND PHARMA
Mankind Pharma Ltd has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Mankind Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1GM | tablet, extended release | Prescription | ORAL | AB | Feb 12, 2020 |
| 500MG | tablet, extended release | Prescription | ORAL | AB | Feb 12, 2020 |
Manufacturing Plant Locations New
Mankind Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Mankind Pharma as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| India |
| |||||
17. MICRO LABS
Micro Labs Ltd has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Micro Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet, extended release | Prescription | ORAL | AB | Feb 27, 2020 |
| 1GM | tablet, extended release | Prescription | ORAL | AB | Feb 27, 2020 |
Manufacturing Plant Locations New
Micro Labs's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Micro Labs as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
18. NOVAST LABS
Novast Laboratories Ltd has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Novast Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet, extended release | Prescription | ORAL | AB | Sep 27, 2023 |
| 1GM | tablet, extended release | Prescription | ORAL | AB | Sep 27, 2023 |
19. PIRAMAL
Piramal Healthcare Uk Ltd has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Piramal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet, extended release | Discontinued | ORAL | N/A | Jul 25, 2023 |
| 1GM | tablet, extended release | Discontinued | ORAL | N/A | Jul 25, 2023 |
20. RISING
Rising Pharma Holdings Inc has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1GM | tablet, extended release | Prescription | ORAL | AB | Jan 28, 2021 |
| 500MG | tablet, extended release | Prescription | ORAL | AB | Jan 28, 2021 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||
| Mexico |
| |||||||||||||||||||
| India |
| |||||||||||||||||||
21. SCIEGEN PHARMS INC
Sciegen Pharmaceuticals Inc has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet, extended release | Prescription | ORAL | AB | Jun 4, 2019 |
| 1GM | tablet, extended release | Prescription | ORAL | AB | Jun 4, 2019 |
22. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1GM | tablet, extended release | Discontinued | ORAL | N/A | May 28, 2019 |
| 500MG | tablet, extended release | Discontinued | ORAL | N/A | May 28, 2019 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||
23. SUNSHINE
Sunshine Lake Pharma Co Ltd has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Sunshine.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1GM | tablet, extended release | Prescription | ORAL | AB | Mar 23, 2020 |
| 500MG | tablet, extended release | Prescription | ORAL | AB | Mar 23, 2020 |
Manufacturing Plant Locations New
Sunshine's manufacturing plants are situated in 6 countries - United States, Peru, India, Thailand, China, Mozambique. Given below are the details of these plant locations as well as the firm names of Sunshine as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||||||||||||||
| Peru |
| |||||||||||||||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||||||||||||||
| Thailand |
| |||||||||||||||||||||||||||||||||||||||||
| China |
| |||||||||||||||||||||||||||||||||||||||||
| Mozambique |
| |||||||||||||||||||||||||||||||||||||||||
24. TORRENT
Torrent Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Torrent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1GM | tablet, extended release | Prescription | ORAL | AB | Feb 4, 2025 |
| 500MG | tablet, extended release | Prescription | ORAL | AB | Feb 4, 2025 |
Manufacturing Plant Locations New
Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||
| United States |
| |||||||||||
25. UNICHEM
Unichem Laboratories Ltd has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Unichem.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet, extended release | Prescription | ORAL | AB | Mar 16, 2023 |
| 1GM | tablet, extended release | Prescription | ORAL | AB | Mar 16, 2023 |
Manufacturing Plant Locations New
Unichem's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Unichem as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||
| United States |
| |||||||||||||
26. VKT PHARMA
Vkt Pharma Private Ltd has filed for 2 different strengths of generic version for Ranolazine. Given below are the details of the strengths of this generic introduced by Vkt Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1GM | tablet, extended release | Prescription | ORAL | AB | Jan 19, 2022 |
| 500MG | tablet, extended release | Prescription | ORAL | AB | Jan 19, 2022 |
Manufacturing Plant Locations New
Vkt Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Vkt Pharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||